Analysts’ Opinions Are Mixed on These Healthcare Stocks: Globus Medical (GMED) and 4D Molecular Therapeutics (FDMT)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Globus Medical (GMED – Research Report) and ...
Yahoo Finance1mon
Globus Medical upgraded to Neutral from Underperform at BofA
BofA analyst Craig Bijou upgraded Globus Medical (GMED) to Neutral from Underperform with a price target of $97, up from $80, after the company preannounced Q4 revenue that was 3% above the Street ...